Top Ad

Flumazenil

Form: Intravenous (IV) injection

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Reference Brands: Romazicon®(US), Anexate®(EU)

Category: Critical Care

Flumazenil is a benzodiazepine antagonist used to reverse sedation from benzodiazepine overdose or during anesthesia recovery. It is administered via IV injection, commonly available as 0.1 mg/mL in 5 mL or 10 mL vials. Leading brands include Romazicon® in the US and Anexate® in the EU, with several generic alternatives available globally. Widely used in emergency care, ICUs, and surgical settings, Flumazenil is a key hospital medicine. Pharma B2B platforms offer reliable sourcing of GMP-certified Flumazenil in bulk, ensuring regulatory-compliant products, secure supply chains, and timely delivery for healthcare providers and institutional buyers worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View More Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View More Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View More Get Enquiry
Nitroprusside

Strength: 50 mg/2 mL vial

Form: Intravenous (IV) injection

Reference Brands: Nitropress®(US), Nitroprussiat Ferrlecit®(EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.